{
  "case_id": "MN16-23712",
  "year": 2016,
  "patient_info": {
    "age_range": "21 to 30",
    "gender": "Female"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [
    "cataplexy",
    "hypersomnia"
  ],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Other",
  "treatments_requested": [
    {
      "name": "Sodium Oxybate",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "FDA approved for narcolepsy with cataplexy"
    }
  ],
  "treatments_tried_but_failed": [],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity"
  ],
  "other_issues": null,
  "guidelines_support": true,
  "guidelines_not_support": null,
  "guidelines_details": "Xyrem is the only FDA approved medication for narcolepsy with cataplexy.",
  "soc_support": true,
  "soc_not_support": null,
  "soc_details": "Xyrem is established as medically necessary for narcolepsy with cataplexy.",
  "study_support": null,
  "study_details": [],
  "key_questions": [
    "medical_necessity"
  ],
  "expedited": false,
  "rationale": "The reviewer found that Xyrem is medically necessary for the treatment of narcolepsy with cataplexy, supported by clinical documentation and literature.",
  "reviewer_credentials": "Board certified in internal medicine with sub-specialty certification in pulmonary disease, actively practicing, and expert in treating similar conditions."
}